Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the pharmaceutical industry, announced the appointment of Derek Hennecke as an independent member of its board of directors.
Hennecke serves on several boards, he’s a chairman of the board of Microsize and Particle Dynamics and board director of Grand River Aseptic Manufacturing, Inceptor Bio, Kineticos Disruptor Fund, and the Friedreich’s Ataxia Research Alliance. Previously, he was founder, president, and chief executive officer of Xcelience, board director of Oragenics, vice president and general manager of MDS Pharma Services, and held various leadership roles at DSM Biologics, DSM Anti-Infectives, and Gist-Brocades in the Netherlands, Mexico, and Egypt.